We are live on
!
Find out more
LP
Lexington Partners Portfolio holdings
AUM
$134M
1-Year Est. Return
1.93%
This Fund
S&P 500
This Quarter
Est. Return
-10.89%
1 Year Est. Return
-1.93%
3 Year Est. Return
+1.27%
5 Year Est. Return
-12.6%
10 Year Est. Return
–
AUM
$194M
AUM Growth
-$26.4M
(-12%)
Cap. Flow
+$1.53M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
+$1.53M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 62.5% |
| 2 | Financials | 20.8% |
| 3 | Technology | 12.33% |
| 4 | Real Estate | 3.64% |
| 5 | Healthcare | 0.73% |
Similar funds
RA
SWM
SA
SA
GEH
BGI
MMCM
STFP
Lexington Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Lexington Partners held 7 positions worth $194M, down 12% from $220M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Lexington Partners's Q2 2022 filing shows 1 new position. Its largest new stake was NGM Biopharmaceuticals, Inc. Common Stock: 110,428 shares worth $1.42M.
By sector, the portfolio is most concentrated in Consumer Staples at 63% of assets, up from 59% a quarter earlier, followed by Financials and Technology.
- Lexington Partners's largest Q2 2022 buy was NGM Biopharmaceuticals, Inc. Common Stock: 110,428 shares worth $1.42M.
- Lexington Partners's ten largest holdings make up 100% of its $194M portfolio in Q2 2022.
- Lexington Partners opened 1 new position and closed 0 in Q2 2022.
- Lexington Partners's portfolio value fell 12% quarter-over-quarter to $194M.
Based on Lexington Partners's 13F filing for Q2 2022, filed 12 Aug 2022.